BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ASINEX Ltd. And SIENABIOTECH Announce Lead Generation Collaboration


10/19/2005 5:10:38 PM

ASINEX Ltd, a worldwide leader in lead generation and lead optimization, will perform computational work for SIENABIOTECH S.p.A., an integrated drug discovery company. ASINEX's computational department based on the information provided by SIENABIOTECH (undisclosed target & undisclosed set of small molecules active toward such target) will create different pharmacophore models and use the results to rank the whole in-house ASINEX library (Platinum Collection 120,000 compounds) based on the resulting docking score. Georg C. Terstappen, V.P. Discovery Research of SIENABIOTECH said "Through this collaboration we expect to enhance the efficiency of our integrated drug discovery process which employs state-of-the-art platform technologies. Using ASINEX' compound collection, flexible docking and de novo ligand design technologies, we believe we can increase the chances of identifying high-quality leads." "ASINEX's computational team, with their efficient lead generation and drug design solutions, have proven to be a creative partner for biotech companies. Our computational department is a part of ASINEX's 'chemistry driven' integrated drug discovery service. Today we are delighted to announce ASINEX's deal with Sienabiotech and we are looking forward to establish a long-term relationship which will also include chemistry services", said Dmitri Genis, ASINEX CEO


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES